Sanofi India Limited

• Sanofi’s Qfitlia Receives Marketing Authorisation In India For Haemophilia A And B
  BW Healthcare · 21 Oct 2026
• Sanofi’s Qfitlia wins approval in India
  The Pharma Letter · 21 Oct 2026
• Sanofi’s Qfitlia® (Fitusiran) receives marketing authorisation in India for Haemophilia treatment
  BioSpectrum India · 21 Oct 2026
• Sanofi Gets CDSCO Nod for Qfitlia: Haemophilia Bleeding Drug
  Rediff MoneyWiz · 21 Oct 2026
• Sanofi India (NSEI:SANOFI) Stock Forecast & Analyst Predictions
  Simply Wall Street · 05 Oct 2026
• Dividend income at risk? 8 stocks with inconsistent dividend payout: Indian Oil, Sanofi India, UTI AMC, and more
  TradingView · 30 Sep 2026
• Sanofi India served ₹16.4 crore tax notice over discrepancies in GST filing
  pharma.economictimes.indiatimes.com · 30 Sep 2026
• Dividend income at risk? 8 stocks with inconsistent dividend payout: Indian Oil, Sanofi India, UTI AMC, and more
  Livemint · 30 Sep 2026
• Sanofi India receives ₹16.40 Cr GST notice from Gujarat for FY23
  scanx.trade · 28 Sep 2026
• Sanofi India Faces Rs 23.74 Crore GST Demand Over Alleged Excess ITC Claim for FY23
  Medical Dialogues · 27 Sep 2026
• Sanofi India receives Rs 23.74 crore GST show cause notice
  Business Standard · 26 Sep 2026
• Sanofi Healthcare buys 15.2% stake in Sanofi India for Rs 1,068 crore
  The Economic Times · 24 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →